Biomaterials, Biodegradables and Biomimetics Research Group

Comunications - Poster

Methacrylated gellan-gum:manganese dioxide nanoreactors as contrast agent for MRI imaging and scavenger of Reactive Oxygen Species

Abstract

Oxidative stress has been described in diseases such as Amyotrophic Lateral Sclerosis, presenting a potential target for the development of new therapies. Magnetic Resonance Imaging (MRI) is a technique frequently used to study the nervous system. Manganese ions (Mn2+) are part of a healthy brain and can be used for long-term T1-weight imaging due to its ability to be a contrast agent. Thus, Manganese Enhanced MRI has been used to guide intrathecal drug/cell delivery. Additionally, the ability to scavenge Reactive Oxygen Species (ROS) has been studied, using manganese dioxide (MnO2) nanoparticles, which decompose hydrogen peroxide in water, oxygen and Mn2+. In this work, we propose the development of nanoreactores composed of a methacrylated gellan-gum (GG-MA) blended with manganese dioxide (MnO2) nanoparticles, which will be delivered and guided by MRI. Due to its biocompatibility, biodegradability, easy functionalization and high affinity to Mn2+, GG-MA matrix was used to reduce the toxicity of the MnO2 nanoparticles. A previously described protocol was followed to produce GG-MA, and further characterization was performed by FTIR and 1H-NMR. Regarding the MnO2 nanoparticles, a comparison between synthetized and commercially available ones was performed. The nanoreactors were submitted to several tests regarding their rheology, stability, permeability and morphology. Cell viability and ROS scavenging ability of these nanoreactors will also be studied.

Journal
1st Discoveries Forum on Regenerative and Precision Medicine
Keywords
GG-MA, MnO2 nanoreactors, MRI, ROS scavenging
Rights
Open Access
Peer Reviewed
Yes
Status
published
Project
NanoTech4ALS
Year of Publication
2019
Date Published
2019-09-25
Search Google ScholarGenerate BibTexDownload RTF
This website uses cookies. By using this website you consent to our use of these cookies. For more information visit our Policy Page.